Kazakhstan is set to actively
advance in the field of theranostics. The nuclear medicine area, which combines
both diagnostics and treatment of oncological and other diseases, took center stage
at an international research-to-practice conference in Astana. Leading
specialists from Kazakhstan, Georgia, Armenia, Russia, Uzbekistan, and
Azerbaijan gathered at the Medical Center Hospital of the President’s Affairs
Administration. Among them are oncologists, radio chemists, urologists, medical
physicists, and radiology experts. Over the course of two days, they will
conduct masterclasses and exchange practical knowledge in radiopharmaceutical
production, modern diagnostic techniques, and treatment methods for various
diseases, including autoimmune, oncological, cardiological, and endocrine
disorders.
“I would like to share my
experience of interdisciplinary cooperation as this area relies on the
collaboration of all forces and specialists, including surgeons, pathologists,
and molecular radiologists. We must advance using our knowledge, draw from the
experience of global leaders, learn, develop, display creativity, and train
young people. That is the comprehensive task before us,” said Pavel Rumyantsev,
President of Russia’s Theranostics Development Association.
Over the next three years,
Kazakhstan aims to train dozens of domestic specialists at leading foreign
Positron Emission Tomography (PET) centers, cyclotron production complexes, and
nuclear medicine facilities. The first team to acquire international experience
will depart in the near future.
“This year, a project has been
launched with the support of the International Atomic Energy Agency (IAEA) in
Vienna, Austria. The initiative, which won, focuses on the development and
introduction of new radiopharmaceuticals for diagnostics, manufactured at our
center. More than 20 specialists in production, including physicists, chemists,
and nuclear scientists, along with over 15 doctors specializing in diagnostics,
will undergo training. We are particularly focused on European centers,
including Sweden and Germany,” said Aigul Saduakassova, Head of the Nuclear
Medicine Center at the Medical Center Hospital of the President’s Affairs
Administration of the Republic of Kazakhstan.
